ADACTIVE's ambitious goal is the advanced design of high-performance architectured materials and active metamaterials for cutting-edge and smart applications in many engineering and technological fields. A multidisciplinary design approach is developed, which combines physical-mathematical models, computational methods, data-driven optimization techniques, and innovative experimental test protocols to harness the complexity of phase heterogeneities, multi-field interactions, multi-scale bridges, geometrical and mechanical nonlinearities, multi-frequency energy sources and harvesters. This optimal design approach is conceived to exploit the features of the breakthrough 4D printing technology overcoming the limitations of 3D printing. Such innovation adds the dimension of transformation over time, allowing the additive manufacturing of objects that can be activated in a controlled fashion to change shape, configuration, or physical properties. ADACTIVE aims at developing technologies that pave the way to almost endless opportunities to design avant-garde active materials and metamaterials, able to morph their microstructure depending on external stimuli. Advancement of knowledge concerns the modelling, conceptualization and design, together with prototyping and proof-of-concept of reprogrammable multi-functional metadevices for wave propagation control, energy harvesting, sensing, self-healing and stress-controlled failure programs. The four Research Units have comprehensive analytical, computational, and experimental expertise in the field, fundamental to pursuing the project goal.
1. metamaterials
2. computational mechanics
3. computational engineering
4. mechanics of materials
5. architetture active materials
6. 3D-4D printing
Sono previste attività di ricerca che prevedono sperimentazioni passibili di giudizio da parte del Comitato Etico? No
Studio con feti ed embrioni umani
Studio con campioni biologici umani
Studio che contempla l’utilizzo di animali
Studio con esseri umani
Uso di animali ai fini sperimentali secondo il decreto legislativo 26/2014
Sperimentazione con esseri umani
Raccolta e organizzazione di informazioni personali sensibili relativi a esseri umani (archivi, registri, banche dati)
Sperimentazione clinica di farmaco ex D.lgs. 24 giugno 2003, n. 211
Studi che coinvolgono paesi non UE
Studi che implicano questioni ambientali, sanitarie e di sicurezza
Studi che possibile uso duale
Studi con possibili sviluppi a fini criminali / terroristici
Altri aspetti etici
Ambiti specifici previsti dal Programma H2020/Horizon Europe
Nessuno